var savedState = '{"tables":{"Histological features":{"name":"Histological features","data":[{"measure_id":"Az01_CA1_AT8","CE Gundersen":0.07,"Patient":"Az01","No of cells/volume (mm3)":2779.1323058648,"Total markers counted":189,"Region":"CA1","Total population estimated":26296.4,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.46209},{"measure_id":"Az01_CA1_BetaA","CE Gundersen":0.08,"Patient":"Az01","No of cells/volume (mm3)":1143.6336093435,"Total markers counted":178,"Region":"CA1","Total population estimated":4892.03,"% Occupied by plaques":2.0740896825,"Labeling":"BetaA","Total nucleators counted":178,"Plaque AVG volume":0.000018136,"Region volume estimation":4.27762},{"measure_id":"Az01_CA1_NISSL","CE Gundersen":0.09,"Patient":"Az01","No of cells/volume (mm3)":8506.8430223349,"Total markers counted":140,"Region":"CA1","Total population estimated":37592.59,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.4191},{"measure_id":"Az01_CA1_NeuN","CE Gundersen":0.04,"Patient":"Az01","No of cells/volume (mm3)":11660.878195776399,"Total markers counted":616,"Region":"CA1","Total population estimated":97515.26,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.3626},{"measure_id":"Az01_CA1_PHF1","CE Gundersen":0.06,"Patient":"Az01","No of cells/volume (mm3)":3549.1344510448,"Total markers counted":291,"Region":"CA1","Total population estimated":28116.74,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.92214},{"measure_id":"Az01_CA3_AT8","CE Gundersen":0.13,"Patient":"Az01","No of cells/volume (mm3)":589.7606413792,"Total markers counted":63,"Region":"CA3","Total population estimated":7635.69,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":12.9471},{"measure_id":"Az01_CA3_BetaA","CE Gundersen":0.12,"Patient":"Az01","No of cells/volume (mm3)":196.30758116259997,"Total markers counted":70,"Region":"CA3","Total population estimated":1923.83,"% Occupied by plaques":0.6378676219,"Labeling":"BetaA","Total nucleators counted":70,"Plaque AVG volume":0.000032493275,"Region volume estimation":9.80008},{"measure_id":"Az01_CA3_NISSL","CE Gundersen":0.08,"Patient":"Az01","No of cells/volume (mm3)":11679.2280032527,"Total markers counted":161,"Region":"CA3","Total population estimated":43231.48,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.70157},{"measure_id":"Az01_CA3_NeuN","CE Gundersen":0.03,"Patient":"Az01","No of cells/volume (mm3)":11867.8437120366,"Total markers counted":1291,"Region":"CA3","Total population estimated":51092.61,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.30513},{"measure_id":"Az01_CA3_PHF1","CE Gundersen":0.13,"Patient":"Az01","No of cells/volume (mm3)":710.0853652655001,"Total markers counted":64,"Region":"CA3","Total population estimated":6183.75,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.70846},{"measure_id":"Az01_DG_AT8","CE Gundersen":0.05,"Patient":"Az01","No of cells/volume (mm3)":870.0043135236,"Total markers counted":455,"Region":"DG","Total population estimated":12504.92,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":14.3734},{"measure_id":"Az01_DG_BetaA","CE Gundersen":0.11,"Patient":"Az01","No of cells/volume (mm3)":239.2613623319,"Total markers counted":79,"Region":"DG","Total population estimated":3126.5,"% Occupied by plaques":1.2844378014,"Labeling":"BetaA","Total nucleators counted":79,"Plaque AVG volume":0.000053683460999999995,"Region volume estimation":13.0673},{"measure_id":"Az01_DG_PHF1","CE Gundersen":0.15,"Patient":"Az01","No of cells/volume (mm3)":156.728488666,"Total markers counted":44,"Region":"DG","Total population estimated":1209.27,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.7157},{"measure_id":"Az01_SUB_AT8","CE Gundersen":0.09,"Patient":"Az01","No of cells/volume (mm3)":420.935298322,"Total markers counted":125,"Region":"SUB","Total population estimated":4947,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":11.7524},{"measure_id":"Az01_SUB_BetaA","CE Gundersen":0.1,"Patient":"Az01","No of cells/volume (mm3)":932.5897415757,"Total markers counted":108,"Region":"SUB","Total population estimated":2968.2,"% Occupied by plaques":3.8830143946,"Labeling":"BetaA","Total nucleators counted":108,"Plaque AVG volume":0.000041636898,"Region volume estimation":3.18275},{"measure_id":"Az01_SUB_PHF1","CE Gundersen":0.1,"Patient":"Az01","No of cells/volume (mm3)":721.2420142486,"Total markers counted":108,"Region":"SUB","Total population estimated":4274.21,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.9261800000000004},{"measure_id":"Az02_CA1_AT8","CE Gundersen":0.08,"Patient":"Az02","No of cells/volume (mm3)":2462.4961479199,"Total markers counted":173,"Region":"CA1","Total population estimated":32762.28,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":13.3045},{"measure_id":"Az02_CA1_BetaA","CE Gundersen":0.07,"Patient":"Az02","No of cells/volume (mm3)":702.5827342588001,"Total markers counted":198,"Region":"CA1","Total population estimated":5441.7,"% Occupied by plaques":1.3083523078000001,"Labeling":"BetaA","Total nucleators counted":198,"Plaque AVG volume":0.000018622,"Region volume estimation":7.74528},{"measure_id":"Az02_CA1_NISSL","CE Gundersen":0.07,"Patient":"Az02","No of cells/volume (mm3)":10102.0540426151,"Total markers counted":256,"Region":"CA1","Total population estimated":91654.32,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.07284},{"measure_id":"Az02_CA1_NeuN","CE Gundersen":0.05,"Patient":"Az02","No of cells/volume (mm3)":15580.3785253074,"Total markers counted":487,"Region":"CA1","Total population estimated":77094.05,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.94815},{"measure_id":"Az02_CA1_PHF1","CE Gundersen":0.05,"Patient":"Az02","No of cells/volume (mm3)":4895.6759398859,"Total markers counted":368,"Region":"CA1","Total population estimated":35556.56,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.26285},{"measure_id":"Az02_CA3_AT8","CE Gundersen":0.15,"Patient":"Az02","No of cells/volume (mm3)":1046.6034693241,"Total markers counted":48,"Region":"CA3","Total population estimated":6678.45,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.381069999999999},{"measure_id":"Az02_CA3_BetaA","CE Gundersen":0.13,"Patient":"Az02","No of cells/volume (mm3)":226.1467214464,"Total markers counted":57,"Region":"CA3","Total population estimated":1566.55,"% Occupied by plaques":1.1729106718,"Labeling":"BetaA","Total nucleators counted":57,"Plaque AVG volume":0.000051865,"Region volume estimation":6.92714},{"measure_id":"Az02_CA3_NISSL","CE Gundersen":0.08,"Patient":"Az02","No of cells/volume (mm3)":8005.1472757480005,"Total markers counted":144,"Region":"CA3","Total population estimated":51555.55,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.4403},{"measure_id":"Az02_CA3_NeuN","CE Gundersen":0.05,"Patient":"Az02","No of cells/volume (mm3)":9912.2970140087,"Total markers counted":365,"Region":"CA3","Total population estimated":57780.96,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.829219999999999},{"measure_id":"Az02_CA3_PHF1","CE Gundersen":0.13,"Patient":"Az02","No of cells/volume (mm3)":359.8860079613,"Total markers counted":62,"Region":"CA3","Total population estimated":2453.71,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.81802},{"measure_id":"Az02_DG_AT8","CE Gundersen":0.05,"Patient":"Az02","No of cells/volume (mm3)":762.5235126565,"Total markers counted":413,"Region":"DG","Total population estimated":11350.62,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":14.8856},{"measure_id":"Az02_DG_BetaA","CE Gundersen":0.15,"Patient":"Az02","No of cells/volume (mm3)":181.1929573119,"Total markers counted":46,"Region":"DG","Total population estimated":1820.5,"% Occupied by plaques":0.9947377212,"Labeling":"BetaA","Total nucleators counted":46,"Plaque AVG volume":0.000054899359000000006,"Region volume estimation":10.0473},{"measure_id":"Az02_DG_PHF1","CE Gundersen":0.11,"Patient":"Az02","No of cells/volume (mm3)":465.5572395454,"Total markers counted":86,"Region":"DG","Total population estimated":3403.54,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.3106800000000005},{"measure_id":"Az02_SUB_AT8","CE Gundersen":0.11,"Patient":"Az02","No of cells/volume (mm3)":496.0703111519,"Total markers counted":77,"Region":"SUB","Total population estimated":3047.35,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.1429800000000006},{"measure_id":"Az02_SUB_BetaA","CE Gundersen":0.09,"Patient":"Az02","No of cells/volume (mm3)":834.8288423718,"Total markers counted":137,"Region":"SUB","Total population estimated":3765.22,"% Occupied by plaques":6.853970926000001,"Labeling":"BetaA","Total nucleators counted":137,"Plaque AVG volume":0.000082100313,"Region volume estimation":4.51017},{"measure_id":"Az02_SUB_PHF1","CE Gundersen":0.08,"Patient":"Az02","No of cells/volume (mm3)":3117.1961011255,"Total markers counted":160,"Region":"SUB","Total population estimated":15459.36,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.95938},{"measure_id":"Az03_CA1_AT8","CE Gundersen":0.07,"Patient":"Az03","No of cells/volume (mm3)":3066.2706439456,"Total markers counted":207,"Region":"CA1","Total population estimated":26134.07,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.52308},{"measure_id":"Az03_CA1_BetaA","CE Gundersen":0.05,"Patient":"Az03","No of cells/volume (mm3)":828.3406297356,"Total markers counted":358,"Region":"CA1","Total population estimated":9839.03,"% Occupied by plaques":2.5614416137,"Labeling":"BetaA","Total nucleators counted":358,"Plaque AVG volume":0.000030922564,"Region volume estimation":11.878},{"measure_id":"Az03_CA1_NISSL","CE Gundersen":0.06,"Patient":"Az03","No of cells/volume (mm3)":10507.9616165274,"Total markers counted":308,"Region":"CA1","Total population estimated":110271.6,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":10.4941},{"measure_id":"Az03_CA1_NeuN","CE Gundersen":0.04,"Patient":"Az03","No of cells/volume (mm3)":15557.9105274895,"Total markers counted":758,"Region":"CA1","Total population estimated":119994.43,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.71276},{"measure_id":"Az03_CA1_PHF1","CE Gundersen":0.04,"Patient":"Az03","No of cells/volume (mm3)":6330.5362271363,"Total markers counted":566,"Region":"CA1","Total population estimated":54687.54,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.638689999999999},{"measure_id":"Az03_CA3_AT8","CE Gundersen":0.13,"Patient":"Az03","No of cells/volume (mm3)":1212.4605854955,"Total markers counted":60,"Region":"CA3","Total population estimated":7575.09,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.2477},{"measure_id":"Az03_CA3_BetaA","CE Gundersen":0.1,"Patient":"Az03","No of cells/volume (mm3)":245.5519779509,"Total markers counted":95,"Region":"CA3","Total population estimated":3759.72,"% Occupied by plaques":1.0447905658,"Labeling":"BetaA","Total nucleators counted":95,"Plaque AVG volume":0.000042548652000000003,"Region volume estimation":15.3113},{"measure_id":"Az03_CA3_NISSL","CE Gundersen":0.07,"Patient":"Az03","No of cells/volume (mm3)":8911.4649487241,"Total markers counted":204,"Region":"CA3","Total population estimated":73037.03,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.19585},{"measure_id":"Az03_CA3_NeuN","CE Gundersen":0.04,"Patient":"Az03","No of cells/volume (mm3)":12572.8041523111,"Total markers counted":710,"Region":"CA3","Total population estimated":112395.84,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.9396},{"measure_id":"Az03_CA3_PHF1","CE Gundersen":0.14,"Patient":"Az03","No of cells/volume (mm3)":220.6382620672,"Total markers counted":54,"Region":"CA3","Total population estimated":2137.1,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.685989999999999},{"measure_id":"Az03_DG_AT8","CE Gundersen":0.05,"Patient":"Az03","No of cells/volume (mm3)":1170.6290040208999,"Total markers counted":369,"Region":"DG","Total population estimated":9735.7,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.31664},{"measure_id":"Az03_DG_BetaA","CE Gundersen":0.1,"Patient":"Az03","No of cells/volume (mm3)":228.38612671470003,"Total markers counted":109,"Region":"DG","Total population estimated":4313.78,"% Occupied by plaques":0.9628069376,"Labeling":"BetaA","Total nucleators counted":109,"Plaque AVG volume":0.000042156999999999996,"Region volume estimation":18.8881},{"measure_id":"Az03_DG_PHF1","CE Gundersen":0.07,"Patient":"Az03","No of cells/volume (mm3)":755.9184060261,"Total markers counted":238,"Region":"DG","Total population estimated":6541.03,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.653089999999999},{"measure_id":"Az03_SUB_AT8","CE Gundersen":0.08,"Patient":"Az03","No of cells/volume (mm3)":1497.452621377,"Total markers counted":142,"Region":"SUB","Total population estimated":9146.8,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.10824},{"measure_id":"Az03_SUB_BetaA","CE Gundersen":0.08,"Patient":"Az03","No of cells/volume (mm3)":874.1767601964999,"Total markers counted":163,"Region":"SUB","Total population estimated":4479.78,"% Occupied by plaques":5.1392360445,"Labeling":"BetaA","Total nucleators counted":163,"Plaque AVG volume":0.000058789438,"Region volume estimation":5.124569999999999},{"measure_id":"Az03_SUB_PHF1","CE Gundersen":0.08,"Patient":"Az03","No of cells/volume (mm3)":2539.7367240508997,"Total markers counted":150,"Region":"SUB","Total population estimated":14493.16,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.70656},{"measure_id":"Az04_CA1_AT8","CE Gundersen":0.1,"Patient":"Az04","No of cells/volume (mm3)":2400.2941013604,"Total markers counted":103,"Region":"CA1","Total population estimated":19505.87,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.12645},{"measure_id":"Az04_CA1_BetaA","CE Gundersen":0.08,"Patient":"Az04","No of cells/volume (mm3)":2398.5815460546,"Total markers counted":174,"Region":"CA1","Total population estimated":4782.1,"% Occupied by plaques":4.7815891021,"Labeling":"BetaA","Total nucleators counted":174,"Plaque AVG volume":0.00001993507,"Region volume estimation":1.9937200000000002},{"measure_id":"Az04_CA1_NISSL","CE Gundersen":0.11,"Patient":"Az04","No of cells/volume (mm3)":2497.890439579,"Total markers counted":84,"Region":"CA1","Total population estimated":11692.8,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.68107},{"measure_id":"Az04_CA1_NeuN","CE Gundersen":0.09,"Patient":"Az04","No of cells/volume (mm3)":3200.1484834119,"Total markers counted":113,"Region":"CA1","Total population estimated":17888.35,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.58985},{"measure_id":"Az04_CA1_PHF1","CE Gundersen":0.04,"Patient":"Az04","No of cells/volume (mm3)":12803.431374101201,"Total markers counted":837,"Region":"CA1","Total population estimated":80871.85,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.31642},{"measure_id":"Az04_CA3_AT8","CE Gundersen":0.14,"Patient":"Az04","No of cells/volume (mm3)":538.3588046666999,"Total markers counted":50,"Region":"CA3","Total population estimated":9468.87,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":17.5884},{"measure_id":"Az04_CA3_BetaA","CE Gundersen":0.09,"Patient":"Az04","No of cells/volume (mm3)":586.2422946618,"Total markers counted":127,"Region":"CA3","Total population estimated":3517.87,"% Occupied by plaques":2.9520423035000003,"Labeling":"BetaA","Total nucleators counted":127,"Plaque AVG volume":0.000050355328,"Region volume estimation":6.00071},{"measure_id":"Az04_CA3_NISSL","CE Gundersen":0.08,"Patient":"Az04","No of cells/volume (mm3)":6326.0389116844,"Total markers counted":168,"Region":"CA3","Total population estimated":45111.11,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.1310199999999995},{"measure_id":"Az04_CA3_NeuN","CE Gundersen":0.04,"Patient":"Az04","No of cells/volume (mm3)":1957.0660794438,"Total markers counted":844,"Region":"CA3","Total population estimated":23195.93,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":11.8524},{"measure_id":"Az04_CA3_PHF1","CE Gundersen":1,"Patient":"Az04","No of cells/volume (mm3)":3662.034019335,"Total markers counted":414,"Region":"CA3","Total population estimated":40001.13,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":10.9232},{"measure_id":"Az04_DG_AT8","CE Gundersen":0.04,"Patient":"Az04","No of cells/volume (mm3)":2243.9294344029,"Total markers counted":772,"Region":"DG","Total population estimated":30552.67,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":13.6157},{"measure_id":"Az04_DG_BetaA","CE Gundersen":0.07,"Patient":"Az04","No of cells/volume (mm3)":540.6817821642,"Total markers counted":250,"Region":"DG","Total population estimated":9893.99,"% Occupied by plaques":2.9896758541,"Labeling":"BetaA","Total nucleators counted":250,"Plaque AVG volume":0.000055294555,"Region volume estimation":18.2991},{"measure_id":"Az04_DG_PHF1","CE Gundersen":0.08,"Patient":"Az04","No of cells/volume (mm3)":448.7012515081,"Total markers counted":156,"Region":"DG","Total population estimated":6173.86,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":13.7594},{"measure_id":"Az04_SUB_AT8","CE Gundersen":0.12,"Patient":"Az04","No of cells/volume (mm3)":514.5214364899,"Total markers counted":74,"Region":"SUB","Total population estimated":2928.62,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.69193},{"measure_id":"Az04_SUB_BetaA","CE Gundersen":0.07,"Patient":"Az04","No of cells/volume (mm3)":4375.8394978411,"Total markers counted":243,"Region":"SUB","Total population estimated":6678.45,"% Occupied by plaques":13.2137133424,"Labeling":"BetaA","Total nucleators counted":243,"Plaque AVG volume":0.000030197,"Region volume estimation":1.52621},{"measure_id":"Az04_SUB_PHF1","CE Gundersen":0.1,"Patient":"Az04","No of cells/volume (mm3)":2307.2247765841003,"Total markers counted":106,"Region":"SUB","Total population estimated":10241.84,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.439030000000001},{"measure_id":"Az05_CA1_AT8","CE Gundersen":0.06,"Patient":"Az05","No of cells/volume (mm3)":3092.9712460064,"Total markers counted":251,"Region":"CA1","Total population estimated":47533.71,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":15.3683},{"measure_id":"Az05_CA1_BetaA","CE Gundersen":0.08,"Patient":"Az05","No of cells/volume (mm3)":377.04228946989997,"Total markers counted":172,"Region":"CA1","Total population estimated":4727.13,"% Occupied by plaques":1.7812085924,"Labeling":"BetaA","Total nucleators counted":172,"Plaque AVG volume":0.000047241613,"Region volume estimation":12.5374},{"measure_id":"Az05_CA1_NISSL","CE Gundersen":0.05,"Patient":"Az05","No of cells/volume (mm3)":15325.1272997837,"Total markers counted":461,"Region":"CA1","Total population estimated":123787.03,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.07739},{"measure_id":"Az05_CA1_NeuN","CE Gundersen":0.04,"Patient":"Az05","No of cells/volume (mm3)":17895.9467434096,"Total markers counted":895,"Region":"CA1","Total population estimated":221378.23,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":12.3703},{"measure_id":"Az05_CA1_PHF1","CE Gundersen":0.06,"Patient":"Az05","No of cells/volume (mm3)":3601.8200685303004,"Total markers counted":245,"Region":"CA1","Total population estimated":23672.17,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.57228},{"measure_id":"Az05_CA3_AT8","CE Gundersen":0.16,"Patient":"Az05","No of cells/volume (mm3)":409.1503008242,"Total markers counted":37,"Region":"CA3","Total population estimated":5147.97,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":12.5821},{"measure_id":"Az05_CA3_BetaA","CE Gundersen":0.13,"Patient":"Az05","No of cells/volume (mm3)":182.96249846990003,"Total markers counted":62,"Region":"CA3","Total population estimated":1703.97,"% Occupied by plaques":0.5930678707,"Labeling":"BetaA","Total nucleators counted":62,"Plaque AVG volume":0.000032414722999999996,"Region volume estimation":9.31322},{"measure_id":"Az05_CA3_NISSL","CE Gundersen":0.08,"Patient":"Az05","No of cells/volume (mm3)":8418.087388915501,"Total markers counted":173,"Region":"CA3","Total population estimated":46453.7,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.51832},{"measure_id":"Az05_CA3_NeuN","CE Gundersen":0.05,"Patient":"Az05","No of cells/volume (mm3)":8978.3262973724,"Total markers counted":424,"Region":"CA3","Total population estimated":67120.89,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.47588},{"measure_id":"Az05_CA3_PHF1","CE Gundersen":0.18,"Patient":"Az05","No of cells/volume (mm3)":111.9703989249,"Total markers counted":32,"Region":"CA3","Total population estimated":1266.43,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":11.3104},{"measure_id":"Az05_DG_AT8","CE Gundersen":0.13,"Patient":"Az05","No of cells/volume (mm3)":93.4809084924,"Total markers counted":62,"Region":"DG","Total population estimated":1703.97,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":18.227999999999998},{"measure_id":"Az05_DG_BetaA","CE Gundersen":0.09,"Patient":"Az05","No of cells/volume (mm3)":205.4746229325,"Total markers counted":119,"Region":"DG","Total population estimated":4709.54,"% Occupied by plaques":0.5189456598,"Labeling":"BetaA","Total nucleators counted":119,"Plaque AVG volume":0.000025255949,"Region volume estimation":22.9203},{"measure_id":"Az05_DG_PHF1","CE Gundersen":0.11,"Patient":"Az05","No of cells/volume (mm3)":135.2122245064,"Total markers counted":84,"Region":"DG","Total population estimated":2308.6,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":17.0739},{"measure_id":"Az05_SUB_AT8","CE Gundersen":0.1,"Patient":"Az05","No of cells/volume (mm3)":857.33701912,"Total markers counted":104,"Region":"SUB","Total population estimated":10048.59,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":11.7207},{"measure_id":"Az05_SUB_BetaA","CE Gundersen":0.09,"Patient":"Az05","No of cells/volume (mm3)":482.07666191550004,"Total markers counted":135,"Region":"SUB","Total population estimated":3710.25,"% Occupied by plaques":1.5389693872,"Labeling":"BetaA","Total nucleators counted":135,"Plaque AVG volume":0.000031923748,"Region volume estimation":7.696389999999999},{"measure_id":"Az05_SUB_PHF1","CE Gundersen":0.1,"Patient":"Az05","No of cells/volume (mm3)":881.5006271256,"Total markers counted":92,"Region":"SUB","Total population estimated":7407.62,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.40342},{"measure_id":"Az06_CA1_AT8","CE Gundersen":0.09,"Patient":"Az06","No of cells/volume (mm3)":2484.1192868732996,"Total markers counted":127,"Region":"CA1","Total population estimated":24050.92,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.68187},{"measure_id":"Az06_CA1_BetaA","CE Gundersen":0.09,"Patient":"Az06","No of cells/volume (mm3)":539.8941637796,"Total markers counted":129,"Region":"CA1","Total population estimated":3545.35,"% Occupied by plaques":1.1394717376999999,"Labeling":"BetaA","Total nucleators counted":129,"Plaque AVG volume":0.000021105465,"Region volume estimation":6.56675},{"measure_id":"Az06_CA1_NISSL","CE Gundersen":0.08,"Patient":"Az06","No of cells/volume (mm3)":7162.1396593545,"Total markers counted":181,"Region":"CA1","Total population estimated":48601.85,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.785939999999999},{"measure_id":"Az06_CA1_NeuN","CE Gundersen":0.07,"Patient":"Az06","No of cells/volume (mm3)":7010.8425882363,"Total markers counted":197,"Region":"CA1","Total population estimated":48727.95,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.9503699999999995},{"measure_id":"Az06_CA1_PHF1","CE Gundersen":0.04,"Patient":"Az06","No of cells/volume (mm3)":11335.150913533602,"Total markers counted":676,"Region":"CA1","Total population estimated":65315.86,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.76224},{"measure_id":"Az06_CA3_AT8","CE Gundersen":0.12,"Patient":"Az06","No of cells/volume (mm3)":546.3864839876001,"Total markers counted":73,"Region":"CA3","Total population estimated":6500.36,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":11.897},{"measure_id":"Az06_CA3_BetaA","CE Gundersen":0.24,"Patient":"Az06","No of cells/volume (mm3)":40.4726223785,"Total markers counted":17,"Region":"CA3","Total population estimated":467.22,"% Occupied by plaques":0.1891150789,"Labeling":"BetaA","Total nucleators counted":17,"Plaque AVG volume":0.000046726668,"Region volume estimation":11.5441},{"measure_id":"Az06_CA3_NISSL","CE Gundersen":0.07,"Patient":"Az06","No of cells/volume (mm3)":9844.0478672954,"Total markers counted":218,"Region":"CA3","Total population estimated":58537.04,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.94644},{"measure_id":"Az06_CA3_NeuN","CE Gundersen":0.08,"Patient":"Az06","No of cells/volume (mm3)":3473.7222366825,"Total markers counted":188,"Region":"CA3","Total population estimated":29761.15,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.56751},{"measure_id":"Az06_CA3_PHF1","CE Gundersen":0.09,"Patient":"Az06","No of cells/volume (mm3)":1214.1351306443,"Total markers counted":121,"Region":"CA3","Total population estimated":11691.15,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.6292},{"measure_id":"Az06_DG_AT8","CE Gundersen":0.08,"Patient":"Az06","No of cells/volume (mm3)":341.7953906134,"Total markers counted":140,"Region":"DG","Total population estimated":5540.64,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":16.2104},{"measure_id":"Az06_DG_BetaA","CE Gundersen":0.09,"Patient":"Az06","No of cells/volume (mm3)":231.04309430150002,"Total markers counted":125,"Region":"DG","Total population estimated":4986.58,"% Occupied by plaques":0.9332709698,"Labeling":"BetaA","Total nucleators counted":125,"Plaque AVG volume":0.000040393805,"Region volume estimation":21.5829},{"measure_id":"Az06_DG_PHF1","CE Gundersen":0.08,"Patient":"Az06","No of cells/volume (mm3)":331.72873818790003,"Total markers counted":152,"Region":"DG","Total population estimated":4177.46,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":12.593},{"measure_id":"Az06_SUB_AT8","CE Gundersen":0.1,"Patient":"Az06","No of cells/volume (mm3)":1136.580286501,"Total markers counted":108,"Region":"SUB","Total population estimated":10435.08,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.18112},{"measure_id":"Az06_SUB_BetaA","CE Gundersen":0.08,"Patient":"Az06","No of cells/volume (mm3)":606.8431418168,"Total markers counted":149,"Region":"SUB","Total population estimated":4095.02,"% Occupied by plaques":3.9822426319999997,"Labeling":"BetaA","Total nucleators counted":149,"Plaque AVG volume":0.000065622273,"Region volume estimation":6.748069999999999},{"measure_id":"Az06_SUB_PHF1","CE Gundersen":0.08,"Patient":"Az06","No of cells/volume (mm3)":2582.4702571342,"Total markers counted":182,"Region":"SUB","Total population estimated":14654.15,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.6744699999999995},{"measure_id":"Az07_CA1_AT8","CE Gundersen":0.09,"Patient":"Az07","No of cells/volume (mm3)":2346.3703807635998,"Total markers counted":125,"Region":"CA1","Total population estimated":17391.79,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.412210000000001},{"measure_id":"Az07_CA1_BetaA","CE Gundersen":0.09,"Patient":"Az07","No of cells/volume (mm3)":738.3838383838,"Total markers counted":129,"Region":"CA1","Total population estimated":3545.35,"% Occupied by plaques":1.065825394,"Labeling":"BetaA","Total nucleators counted":129,"Plaque AVG volume":0.000014434571000000001,"Region volume estimation":4.8015},{"measure_id":"Az07_CA1_NISSL","CE Gundersen":0.09,"Patient":"Az07","No of cells/volume (mm3)":8534.6753034761,"Total markers counted":154,"Region":"CA1","Total population estimated":21436.8,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":2.51173},{"measure_id":"Az07_CA1_NeuN","CE Gundersen":0.06,"Patient":"Az07","No of cells/volume (mm3)":8961.064623534201,"Total markers counted":271,"Region":"CA1","Total population estimated":42900.38,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.78742},{"measure_id":"Az07_CA1_PHF1","CE Gundersen":0.06,"Patient":"Az07","No of cells/volume (mm3)":7899.9686032365,"Total markers counted":250,"Region":"CA1","Total population estimated":24155.26,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.05764},{"measure_id":"Az07_CA3_AT8","CE Gundersen":0.18,"Patient":"Az07","No of cells/volume (mm3)":501.30038796559995,"Total markers counted":32,"Region":"CA3","Total population estimated":6060.07,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":12.0887},{"measure_id":"Az07_CA3_BetaA","CE Gundersen":0.12,"Patient":"Az07","No of cells/volume (mm3)":264.76806334540004,"Total markers counted":73,"Region":"CA3","Total population estimated":2006.28,"% Occupied by plaques":0.980588592,"Labeling":"BetaA","Total nucleators counted":73,"Plaque AVG volume":0.000037035758,"Region volume estimation":7.5775},{"measure_id":"Az07_CA3_NISSL","CE Gundersen":0.07,"Patient":"Az07","No of cells/volume (mm3)":10899.722334978,"Total markers counted":213,"Region":"CA3","Total population estimated":57194.44,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.247330000000001},{"measure_id":"Az07_CA3_NeuN","CE Gundersen":0.04,"Patient":"Az07","No of cells/volume (mm3)":11719.7922009667,"Total markers counted":586,"Region":"CA3","Total population estimated":92766.14,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.91534},{"measure_id":"Az07_CA3_PHF1","CE Gundersen":0.14,"Patient":"Az07","No of cells/volume (mm3)":594.0832011712,"Total markers counted":49,"Region":"CA3","Total population estimated":6817.58,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":11.4758},{"measure_id":"Az07_DG_AT8","CE Gundersen":0.06,"Patient":"Az07","No of cells/volume (mm3)":1057.1905326483,"Total markers counted":365,"Region":"DG","Total population estimated":14445.24,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":13.6638},{"measure_id":"Az07_DG_BetaA","CE Gundersen":0.16,"Patient":"Az07","No of cells/volume (mm3)":88.5376990501,"Total markers counted":39,"Region":"DG","Total population estimated":1543.46,"% Occupied by plaques":0.46128877840000004,"Labeling":"BetaA","Total nucleators counted":39,"Plaque AVG volume":0.000052100832,"Region volume estimation":17.4328},{"measure_id":"Az07_DG_PHF1","CE Gundersen":0.07,"Patient":"Az07","No of cells/volume (mm3)":486.5952225013,"Total markers counted":246,"Region":"DG","Total population estimated":6760.9,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":13.8943},{"measure_id":"Az07_SUB_AT8","CE Gundersen":0.09,"Patient":"Az07","No of cells/volume (mm3)":1567.9888812151999,"Total markers counted":133,"Region":"SUB","Total population estimated":3655.28,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":2.3311900000000003},{"measure_id":"Az07_SUB_BetaA","CE Gundersen":0.18,"Patient":"Az07","No of cells/volume (mm3)":325.1099943143,"Total markers counted":31,"Region":"SUB","Total population estimated":851.98,"% Occupied by plaques":1.0359359476999999,"Labeling":"BetaA","Total nucleators counted":31,"Plaque AVG volume":0.000031864168,"Region volume estimation":2.62059},{"measure_id":"Az07_SUB_PHF1","CE Gundersen":0.09,"Patient":"Az07","No of cells/volume (mm3)":4086.3057416821002,"Total markers counted":143,"Region":"SUB","Total population estimated":5659.37,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":1.38496},{"measure_id":"Az08_CA1_AT8","CE Gundersen":0.07,"Patient":"Az08","No of cells/volume (mm3)":3932.8750913919002,"Total markers counted":238,"Region":"CA1","Total population estimated":24528.87,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.23688},{"measure_id":"Az08_CA1_BetaA","CE Gundersen":0.08,"Patient":"Az08","No of cells/volume (mm3)":806.0906657799001,"Total markers counted":163,"Region":"CA1","Total population estimated":7466.31,"% Occupied by plaques":3.2096625519,"Labeling":"BetaA","Total nucleators counted":163,"Plaque AVG volume":0.000039817637,"Region volume estimation":9.262369999999999},{"measure_id":"Az08_CA1_NISSL","CE Gundersen":0.09,"Patient":"Az08","No of cells/volume (mm3)":7824.7789926286,"Total markers counted":147,"Region":"CA1","Total population estimated":26314.81,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.36301},{"measure_id":"Az08_CA1_NeuN","CE Gundersen":0.06,"Patient":"Az08","No of cells/volume (mm3)":7535.6162073468995,"Total markers counted":297,"Region":"CA1","Total population estimated":61219.12,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.12397},{"measure_id":"Az08_CA1_PHF1","CE Gundersen":0.05,"Patient":"Az08","No of cells/volume (mm3)":9627.4174591303,"Total markers counted":470,"Region":"CA1","Total population estimated":37843.26,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.9307800000000004},{"measure_id":"Az08_CA3_AT8","CE Gundersen":0.12,"Patient":"Az08","No of cells/volume (mm3)":1274.1037728336998,"Total markers counted":69,"Region":"CA3","Total population estimated":16000.45,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":12.5582},{"measure_id":"Az08_CA3_BetaA","CE Gundersen":0.21,"Patient":"Az08","No of cells/volume (mm3)":123.5142948924,"Total markers counted":23,"Region":"CA3","Total population estimated":1053.53,"% Occupied by plaques":1.0572610334,"Labeling":"BetaA","Total nucleators counted":23,"Plaque AVG volume":0.00008559827300000001,"Region volume estimation":8.52962},{"measure_id":"Az08_CA3_NISSL","CE Gundersen":0.06,"Patient":"Az08","No of cells/volume (mm3)":11655.1419067844,"Total markers counted":340,"Region":"CA3","Total population estimated":60864.2,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.222090000000001},{"measure_id":"Az08_CA3_NeuN","CE Gundersen":0.04,"Patient":"Az08","No of cells/volume (mm3)":12460.075539213001,"Total markers counted":851,"Region":"CA3","Total population estimated":112263.91,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.009889999999999},{"measure_id":"Az08_CA3_PHF1","CE Gundersen":0.07,"Patient":"Az08","No of cells/volume (mm3)":1724.3366500406,"Total markers counted":210,"Region":"CA3","Total population estimated":16908.69,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.80591},{"measure_id":"Az08_DG_AT8","CE Gundersen":0.05,"Patient":"Az08","No of cells/volume (mm3)":911.3933599674001,"Total markers counted":359,"Region":"DG","Total population estimated":23679.64,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":25.9818},{"measure_id":"Az08_DG_BetaA","CE Gundersen":0.14,"Patient":"Az08","No of cells/volume (mm3)":180.4717631398,"Total markers counted":52,"Region":"DG","Total population estimated":3429.92,"% Occupied by plaques":1.1692475155,"Labeling":"BetaA","Total nucleators counted":52,"Plaque AVG volume":0.000064788391,"Region volume estimation":19.0053},{"measure_id":"Az08_DG_PHF1","CE Gundersen":0.08,"Patient":"Az08","No of cells/volume (mm3)":302.0707132561,"Total markers counted":140,"Region":"DG","Total population estimated":3206.39,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":10.6147},{"measure_id":"Az08_SUB_AT8","CE Gundersen":0.15,"Patient":"Az08","No of cells/volume (mm3)":712.2979220087,"Total markers counted":47,"Region":"SUB","Total population estimated":3100.12,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.35228},{"measure_id":"Az08_SUB_BetaA","CE Gundersen":0.09,"Patient":"Az08","No of cells/volume (mm3)":967.9051434588999,"Total markers counted":124,"Region":"SUB","Total population estimated":5679.89,"% Occupied by plaques":4.8689647458,"Labeling":"BetaA","Total nucleators counted":124,"Plaque AVG volume":0.000050304152,"Region volume estimation":5.8682300000000005},{"measure_id":"Az08_SUB_PHF1","CE Gundersen":0.09,"Patient":"Az08","No of cells/volume (mm3)":2120.2055156656,"Total markers counted":127,"Region":"SUB","Total population estimated":10225.73,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.82299},{"measure_id":"Az09_CA1_AT8","CE Gundersen":0.11,"Patient":"Az09","No of cells/volume (mm3)":1078.8555673922,"Total markers counted":82,"Region":"CA1","Total population estimated":7301.77,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.76807},{"measure_id":"Az09_CA1_BetaA","CE Gundersen":0.08,"Patient":"Az09","No of cells/volume (mm3)":1249.6461922327,"Total markers counted":160,"Region":"CA1","Total population estimated":4397.33,"% Occupied by plaques":2.4652930106,"Labeling":"BetaA","Total nucleators counted":160,"Plaque AVG volume":0.000019727927999999998,"Region volume estimation":3.5188599999999997},{"measure_id":"Az09_CA1_NISSL","CE Gundersen":0.13,"Patient":"Az09","No of cells/volume (mm3)":5132.2698484469,"Total markers counted":62,"Region":"CA1","Total population estimated":15777.47,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.07417},{"measure_id":"Az09_CA1_NeuN","CE Gundersen":0.11,"Patient":"Az09","No of cells/volume (mm3)":3645.8263386156,"Total markers counted":83,"Region":"CA1","Total population estimated":13139.23,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.60391},{"measure_id":"Az09_CA1_PHF1","CE Gundersen":0.05,"Patient":"Az09","No of cells/volume (mm3)":14653.710339351,"Total markers counted":466,"Region":"CA1","Total population estimated":45025.43,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.0726299999999998},{"measure_id":"Az09_CA3_AT8","CE Gundersen":0.12,"Patient":"Az09","No of cells/volume (mm3)":1094.7063824579,"Total markers counted":72,"Region":"CA3","Total population estimated":10017.68,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":9.151019999999999},{"measure_id":"Az09_CA3_BetaA","CE Gundersen":0.13,"Patient":"Az09","No of cells/volume (mm3)":190.5797873937,"Total markers counted":67,"Region":"CA3","Total population estimated":1841.38,"% Occupied by plaques":0.9119434169,"Labeling":"BetaA","Total nucleators counted":67,"Plaque AVG volume":0.000047851000000000007,"Region volume estimation":9.66199},{"measure_id":"Az09_CA3_NISSL","CE Gundersen":0.09,"Patient":"Az09","No of cells/volume (mm3)":9277.153752636701,"Total markers counted":133,"Region":"CA3","Total population estimated":35712.96,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.84956},{"measure_id":"Az09_CA3_NeuN","CE Gundersen":0.08,"Patient":"Az09","No of cells/volume (mm3)":3741.7978170049,"Total markers counted":163,"Region":"CA3","Total population estimated":25803.55,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.8960300000000005},{"measure_id":"Az09_CA3_PHF1","CE Gundersen":0.07,"Patient":"Az09","No of cells/volume (mm3)":2252.1285608137,"Total markers counted":197,"Region":"CA3","Total population estimated":19034.36,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.45172},{"measure_id":"Az09_DG_AT8","CE Gundersen":0.07,"Patient":"Az09","No of cells/volume (mm3)":688.3647914625,"Total markers counted":236,"Region":"DG","Total population estimated":9339.94,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":13.5683},{"measure_id":"Az09_DG_BetaA","CE Gundersen":0.08,"Patient":"Az09","No of cells/volume (mm3)":481.49769270089996,"Total markers counted":169,"Region":"DG","Total population estimated":6688.34,"% Occupied by plaques":2.6648873556,"Labeling":"BetaA","Total nucleators counted":169,"Plaque AVG volume":0.000055345797,"Region volume estimation":13.8907},{"measure_id":"Az09_DG_PHF1","CE Gundersen":0.08,"Patient":"Az09","No of cells/volume (mm3)":546.9416323027,"Total markers counted":147,"Region":"DG","Total population estimated":4040.05,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":7.38662},{"measure_id":"Az09_SUB_AT8","CE Gundersen":0.11,"Patient":"Az09","No of cells/volume (mm3)":762.1494501312,"Total markers counted":85,"Region":"SUB","Total population estimated":3363.96,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.41378},{"measure_id":"Az09_SUB_BetaA","CE Gundersen":0.08,"Patient":"Az09","No of cells/volume (mm3)":913.1138992842999,"Total markers counted":144,"Region":"SUB","Total population estimated":3957.6,"% Occupied by plaques":2.4413382109,"Labeling":"BetaA","Total nucleators counted":144,"Plaque AVG volume":0.000026736404,"Region volume estimation":4.33418},{"measure_id":"Az09_SUB_PHF1","CE Gundersen":0.08,"Patient":"Az09","No of cells/volume (mm3)":2177.5906925264003,"Total markers counted":173,"Region":"SUB","Total population estimated":6846.65,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.14414},{"measure_id":"Az10_CA1_AT8","CE Gundersen":0.09,"Patient":"Az10","No of cells/volume (mm3)":3351.3808971958,"Total markers counted":143,"Region":"CA1","Total population estimated":19896.21,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":5.936719999999999},{"measure_id":"Az10_CA1_BetaA","CE Gundersen":0.07,"Patient":"Az10","No of cells/volume (mm3)":4143.5077446638,"Total markers counted":241,"Region":"CA1","Total population estimated":6623.48,"% Occupied by plaques":14.5282341106,"Labeling":"BetaA","Total nucleators counted":241,"Plaque AVG volume":0.000035062645,"Region volume estimation":1.5985200000000002},{"measure_id":"Az10_CA1_NISSL","CE Gundersen":0.08,"Patient":"Az10","No of cells/volume (mm3)":12580.6623440006,"Total markers counted":168,"Region":"CA1","Total population estimated":45111.11,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.58575},{"measure_id":"Az10_CA1_NeuN","CE Gundersen":0.06,"Patient":"Az10","No of cells/volume (mm3)":16897.0560636581,"Total markers counted":273,"Region":"CA1","Total population estimated":67526.55,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.99635},{"measure_id":"Az10_CA1_PHF1","CE Gundersen":0.05,"Patient":"Az10","No of cells/volume (mm3)":8479.565697849399,"Total markers counted":382,"Region":"CA1","Total population estimated":36909.26,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":4.35273},{"measure_id":"Az10_CA3_AT8","CE Gundersen":0.13,"Patient":"Az10","No of cells/volume (mm3)":756.1069464235001,"Total markers counted":58,"Region":"CA3","Total population estimated":10983.89,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":14.5269},{"measure_id":"Az10_CA3_BetaA","CE Gundersen":0.09,"Patient":"Az10","No of cells/volume (mm3)":565.4273044134,"Total markers counted":137,"Region":"CA3","Total population estimated":3765.22,"% Occupied by plaques":5.7658866412,"Labeling":"BetaA","Total nucleators counted":137,"Plaque AVG volume":0.000101974,"Region volume estimation":6.65907},{"measure_id":"Az10_CA3_NISSL","CE Gundersen":0.07,"Patient":"Az10","No of cells/volume (mm3)":7289.929282708001,"Total markers counted":187,"Region":"CA3","Total population estimated":50212.96,"% Occupied by plaques":"NaN","Labeling":"NISSL","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":6.887989999999999},{"measure_id":"Az10_CA3_NeuN","CE Gundersen":0.05,"Patient":"Az10","No of cells/volume (mm3)":8326.2295343862,"Total markers counted":428,"Region":"CA3","Total population estimated":67754.11,"% Occupied by plaques":"NaN","Labeling":"NeuN","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":8.13743},{"measure_id":"Az10_CA3_PHF1","CE Gundersen":0.08,"Patient":"Az10","No of cells/volume (mm3)":1163.8355462639,"Total markers counted":174,"Region":"CA3","Total population estimated":16812.07,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":14.4454},{"measure_id":"Az10_DG_AT8","CE Gundersen":0.05,"Patient":"Az10","No of cells/volume (mm3)":1316.8725175033999,"Total markers counted":413,"Region":"DG","Total population estimated":16344.89,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":12.4119},{"measure_id":"Az10_DG_BetaA","CE Gundersen":0.07,"Patient":"Az10","No of cells/volume (mm3)":528.7050208429,"Total markers counted":216,"Region":"DG","Total population estimated":8548.42,"% Occupied by plaques":3.4291607273,"Labeling":"BetaA","Total nucleators counted":216,"Plaque AVG volume":0.000064859621,"Region volume estimation":16.1686},{"measure_id":"Az10_DG_PHF1","CE Gundersen":0.07,"Patient":"Az10","No of cells/volume (mm3)":372.3387187821,"Total markers counted":228,"Region":"DG","Total population estimated":6266.2,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":16.8293},{"measure_id":"Az10_SUB_AT8","CE Gundersen":0.2,"Patient":"Az10","No of cells/volume (mm3)":781.5433692844999,"Total markers counted":26,"Region":"SUB","Total population estimated":1028.98,"% Occupied by plaques":"NaN","Labeling":"AT8","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":1.3166},{"measure_id":"Az10_SUB_BetaA","CE Gundersen":0.08,"Patient":"Az10","No of cells/volume (mm3)":1825.1255776960002,"Total markers counted":172,"Region":"SUB","Total population estimated":4727.13,"% Occupied by plaques":10.182133951299999,"Labeling":"BetaA","Total nucleators counted":172,"Plaque AVG volume":0.000055788676,"Region volume estimation":2.59003},{"measure_id":"Az10_SUB_PHF1","CE Gundersen":0.08,"Patient":"Az10","No of cells/volume (mm3)":4339.776285672199,"Total markers counted":177,"Region":"SUB","Total population estimated":17101.93,"% Occupied by plaques":"NaN","Labeling":"PHF1","Total nucleators counted":"NaN","Plaque AVG volume":"NaN","Region volume estimation":3.9407400000000004}],"schema":{"dataset_type":"TABLE","index":"measure_id","attributes":{"measure_id":{"attribute_type":"CATEGORICAL","spatial":false,"key":true,"shape":[],"continuous":false,"name":"measure_id"},"Patient":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Patient"},"Labeling":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Labeling"},"Region":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Region"},"Region volume estimation":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"Region volume estimation"},"No of cells/volume (mm3)":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"No of cells/volume (mm3)"},"Total markers counted":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Total markers counted"},"Total population estimated":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"Total population estimated"},"Plaque AVG volume":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Plaque AVG volume"},"% Occupied by plaques":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"% Occupied by plaques"},"Total nucleators counted":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Total nucleators counted"},"CE Gundersen":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"CE Gundersen"}},"quantitative_attrs":["% Occupied by plaques","CE Gundersen","No of cells/volume (mm3)","Plaque AVG volume","Region volume estimation","Total markers counted","Total nucleators counted","Total population estimated"]},"selection":"morpho_dselect"},"Patients characteristics":{"name":"Patients characteristics","data":[{"CERAD Scale":"C","Age at diagnosis":80,"Patient":"Az01","Decease age":90,"Gender":"H","Hypercholesterolemia":"NaN","Disease progression":10,"Post-mortem delay (hours)":4.5,"Braak Scale":"VI","Details on family history of dementia":"Alzheimer","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","MMSE (2)":"NaN","Details of the cerebral atrophy":"Global","Initial behavior alteration":"NaN","Depression/Anxiety/Mood disorders":"NaN","MMSE (1)":14,"Details of cardiovascular diseases":"NaN","Visuospatial agnosia":"NaN","Diabetes":"NaN"},{"CERAD Scale":"C","Age at diagnosis":70,"Patient":"Az02","Decease age":82,"Gender":"M","Hypercholesterolemia":"NaN","Disease progression":12,"Post-mortem delay (hours)":2,"Braak Scale":"V","Details on family history of dementia":"NaN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","MMSE (2)":0,"Details of the cerebral atrophy":"Cortico-subcortical","Initial behavior alteration":"SI","Depression/Anxiety/Mood disorders":"SI","MMSE (1)":15,"Details of cardiovascular diseases":"Hipertensión arterial","Visuospatial agnosia":"SI","Diabetes":"NaN"},{"CERAD Scale":"C","Age at diagnosis":79,"Patient":"Az03","Decease age":81,"Gender":"M","Hypercholesterolemia":"NaN","Disease progression":2,"Post-mortem delay (hours)":5.5,"Braak Scale":"V","Details on family history of dementia":"NaN","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","MMSE (2)":"NaN","Details of the cerebral atrophy":"NaN","Initial behavior alteration":"SI","Depression/Anxiety/Mood disorders":"SI","MMSE (1)":"NaN","Details of cardiovascular diseases":"NaN","Visuospatial agnosia":"SI","Diabetes":"NaN"},{"CERAD Scale":"B","Age at diagnosis":78,"Patient":"Az04","Decease age":87,"Gender":"M","Hypercholesterolemia":"NaN","Disease progression":9,"Post-mortem delay (hours)":5.5,"Braak Scale":"IV","Details on family history of dementia":"Alzheimer","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","MMSE (2)":"NaN","Details of the cerebral atrophy":"NaN","Initial behavior alteration":"NaN","Depression/Anxiety/Mood disorders":"NaN","MMSE (1)":"NaN","Details of cardiovascular diseases":"NaN","Visuospatial agnosia":"NaN","Diabetes":"NaN"},{"CERAD Scale":"C","Age at diagnosis":69,"Patient":"Az05","Decease age":83,"Gender":"M","Hypercholesterolemia":"NaN","Disease progression":14,"Post-mortem delay (hours)":4,"Braak Scale":"V/VI","Details on family history of dementia":"Demencia","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","MMSE (2)":4,"Details of the cerebral atrophy":"Fronto-temporal","Initial behavior alteration":"NaN","Depression/Anxiety/Mood disorders":"SI","MMSE (1)":23,"Details of cardiovascular diseases":"Cardiopatía isquémica","Visuospatial agnosia":"NaN","Diabetes":"NaN"},{"CERAD Scale":"C","Age at diagnosis":69,"Patient":"Az06","Decease age":76,"Gender":"M","Hypercholesterolemia":"NaN","Disease progression":7,"Post-mortem delay (hours)":5,"Braak Scale":"V","Details on family history of dementia":"Demencia","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","MMSE (2)":4,"Details of the cerebral atrophy":"Global","Initial behavior alteration":"NO","Depression/Anxiety/Mood disorders":"SI","MMSE (1)":18,"Details of cardiovascular diseases":"NaN","Visuospatial agnosia":"NaN","Diabetes":"SI"},{"CERAD Scale":"C","Age at diagnosis":89,"Patient":"Az07","Decease age":89,"Gender":"M","Hypercholesterolemia":"NaN","Disease progression":0,"Post-mortem delay (hours)":4.25,"Braak Scale":"VI","Details on family history of dementia":"Alzheimer","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","MMSE (2)":"NaN","Details of the cerebral atrophy":"NaN","Initial behavior alteration":"NaN","Depression/Anxiety/Mood disorders":"NaN","MMSE (1)":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Visuospatial agnosia":"NaN","Diabetes":"NaN"},{"CERAD Scale":"C","Age at diagnosis":77,"Patient":"Az08","Decease age":85,"Gender":"M","Hypercholesterolemia":"SI","Disease progression":8,"Post-mortem delay (hours)":5.75,"Braak Scale":"VI","Details on family history of dementia":"NaN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","MMSE (2)":"NaN","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","Initial behavior alteration":"NO","Depression/Anxiety/Mood disorders":"NO","MMSE (1)":7,"Details of cardiovascular diseases":"Hipertensión arterial","Visuospatial agnosia":"NaN","Diabetes":"SI"},{"CERAD Scale":"C","Age at diagnosis":76,"Patient":"Az09","Decease age":84,"Gender":"M","Hypercholesterolemia":"SI","Disease progression":8,"Post-mortem delay (hours)":5,"Braak Scale":"VI","Details on family history of dementia":"Alzheimer","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","MMSE (2)":8,"Details of the cerebral atrophy":"Cortico-subcortical","Initial behavior alteration":"NO","Depression/Anxiety/Mood disorders":"NO","MMSE (1)":18,"Details of cardiovascular diseases":"Hipertensión arterial","Visuospatial agnosia":"SI","Diabetes":"NaN"},{"CERAD Scale":"C","Age at diagnosis":71,"Patient":"Az10","Decease age":80,"Gender":"M","Hypercholesterolemia":"NaN","Disease progression":9,"Post-mortem delay (hours)":5,"Braak Scale":"V","Details on family history of dementia":"DCL","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","MMSE (2)":21,"Details of the cerebral atrophy":"Ganglios Basales","Initial behavior alteration":"NaN","Depression/Anxiety/Mood disorders":"SI","MMSE (1)":27,"Details of cardiovascular diseases":"NaN","Visuospatial agnosia":"SI","Diabetes":"NaN"}],"schema":{"dataset_type":"TABLE","index":"Patient","attributes":{"Patient":{"attribute_type":"CATEGORICAL","spatial":false,"key":true,"shape":[],"continuous":false,"name":"Patient"},"Gender":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Gender"},"Decease age":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Decease age"},"Age at diagnosis":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Age at diagnosis"},"Disease progression":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Disease progression"},"Post-mortem delay (hours)":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"Post-mortem delay (hours)"},"Braak Scale":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Braak Scale"},"CERAD Scale":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"CERAD Scale"},"MMSE (1)":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"MMSE (1)"},"MMSE (2)":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"MMSE (2)"},"Initial behavior alteration":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Initial behavior alteration"},"Depression/Anxiety/Mood disorders":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Depression/Anxiety/Mood disorders"},"Apraxia / Instrumental impairment":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Apraxia / Instrumental impairment"},"Language impairment":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Language impairment"},"Visuospatial agnosia":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Visuospatial agnosia"},"Diabetes":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Diabetes"},"Hypercholesterolemia":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Hypercholesterolemia"},"Details of cardiovascular diseases":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Details of cardiovascular diseases"},"Details of the cerebral atrophy":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Details of the cerebral atrophy"},"Details on family history of dementia":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Details on family history of dementia"}},"quantitative_attrs":["Age at diagnosis","Decease age","Disease progression","MMSE (1)","MMSE (2)","Post-mortem delay (hours)"]},"selection":"clinic_dselect"},"joined":{"name":"joined","data":[{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":10,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":26296.4,"Region volume estimation":9.46209,"CERAD Scale":"C","No of cells/volume (mm3)":2779.13230586,"Total markers counted":189,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":0.000018135963,"CE Gundersen":0.08,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA1_BetaA","% Occupied by plaques":2.07408968246,"Region":"CA1","Disease progression":10,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":178,"Total population estimated":4892.03,"Region volume estimation":4.27762,"CERAD Scale":"C","No of cells/volume (mm3)":1143.63360934,"Total markers counted":178,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":10,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":37592.59,"Region volume estimation":4.4191,"CERAD Scale":"C","No of cells/volume (mm3)":8506.84302233,"Total markers counted":140,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":10,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":97515.26,"Region volume estimation":8.3626,"CERAD Scale":"C","No of cells/volume (mm3)":11660.878195799998,"Total markers counted":616,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":10,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":28116.74,"Region volume estimation":7.92214,"CERAD Scale":"C","No of cells/volume (mm3)":3549.13445104,"Total markers counted":291,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.13,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":10,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":7635.69,"Region volume estimation":12.9471,"CERAD Scale":"C","No of cells/volume (mm3)":589.760641379,"Total markers counted":63,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":0.000032493275,"CE Gundersen":0.12,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA3_BetaA","% Occupied by plaques":0.63786762193,"Region":"CA3","Disease progression":10,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":70,"Total population estimated":1923.83,"Region volume estimation":9.80008,"CERAD Scale":"C","No of cells/volume (mm3)":196.30758116299998,"Total markers counted":70,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":10,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":43231.48,"Region volume estimation":3.70157,"CERAD Scale":"C","No of cells/volume (mm3)":11679.228003299999,"Total markers counted":161,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.03,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":10,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":51092.61,"Region volume estimation":4.30513,"CERAD Scale":"C","No of cells/volume (mm3)":11867.843712,"Total markers counted":1291,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.13,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":10,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":6183.75,"Region volume estimation":8.70846,"CERAD Scale":"C","No of cells/volume (mm3)":710.085365266,"Total markers counted":64,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":10,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":12504.92,"Region volume estimation":14.3734,"CERAD Scale":"C","No of cells/volume (mm3)":870.0043135239999,"Total markers counted":455,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":0.000053683460999999995,"CE Gundersen":0.11,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_DG_BetaA","% Occupied by plaques":1.28443780136,"Region":"DG","Disease progression":10,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":79,"Total population estimated":3126.5,"Region volume estimation":13.0673,"CERAD Scale":"C","No of cells/volume (mm3)":239.261362332,"Total markers counted":79,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.15,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":10,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":1209.27,"Region volume estimation":7.7157,"CERAD Scale":"C","No of cells/volume (mm3)":156.728488666,"Total markers counted":44,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":10,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":4947,"Region volume estimation":11.7524,"CERAD Scale":"C","No of cells/volume (mm3)":420.935298322,"Total markers counted":125,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":0.000041636898,"CE Gundersen":0.1,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_SUB_BetaA","% Occupied by plaques":3.88301439458,"Region":"SUB","Disease progression":10,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":108,"Total population estimated":2968.2,"Region volume estimation":3.18275,"CERAD Scale":"C","No of cells/volume (mm3)":932.589741576,"Total markers counted":108,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":90,"Plaque AVG volume":"NaN","CE Gundersen":0.1,"MMSE (1)":14,"Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":80,"Patient":"Az01","Post-mortem delay (hours)":4.5,"Gender":"H","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az01_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":10,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":4274.21,"Region volume estimation":5.9261800000000004,"CERAD Scale":"C","No of cells/volume (mm3)":721.2420142489999,"Total markers counted":108,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":"NaN"},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":12,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":32762.28,"Region volume estimation":13.3045,"CERAD Scale":"C","No of cells/volume (mm3)":2462.49614792,"Total markers counted":173,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":0.000018622039,"CE Gundersen":0.07,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA1_BetaA","% Occupied by plaques":1.3083523078100001,"Region":"CA1","Disease progression":12,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":198,"Total population estimated":5441.7,"Region volume estimation":7.74528,"CERAD Scale":"C","No of cells/volume (mm3)":702.582734259,"Total markers counted":198,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":12,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":91654.32,"Region volume estimation":9.07284,"CERAD Scale":"C","No of cells/volume (mm3)":10102.0540426,"Total markers counted":256,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":12,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":77094.05,"Region volume estimation":4.94815,"CERAD Scale":"C","No of cells/volume (mm3)":15580.378525299999,"Total markers counted":487,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":12,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":35556.56,"Region volume estimation":7.26285,"CERAD Scale":"C","No of cells/volume (mm3)":4895.67593989,"Total markers counted":368,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.15,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":12,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":6678.45,"Region volume estimation":6.381069999999999,"CERAD Scale":"C","No of cells/volume (mm3)":1046.60346932,"Total markers counted":48,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":0.000051865031,"CE Gundersen":0.13,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA3_BetaA","% Occupied by plaques":1.17291067184,"Region":"CA3","Disease progression":12,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":57,"Total population estimated":1566.55,"Region volume estimation":6.92714,"CERAD Scale":"C","No of cells/volume (mm3)":226.146721446,"Total markers counted":57,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":12,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":51555.55,"Region volume estimation":6.4403,"CERAD Scale":"C","No of cells/volume (mm3)":8005.14727575,"Total markers counted":144,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":12,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":57780.96,"Region volume estimation":5.829219999999999,"CERAD Scale":"C","No of cells/volume (mm3)":9912.29701401,"Total markers counted":365,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.13,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":12,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":2453.71,"Region volume estimation":6.81802,"CERAD Scale":"C","No of cells/volume (mm3)":359.88600796099996,"Total markers counted":62,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":12,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":11350.62,"Region volume estimation":14.8856,"CERAD Scale":"C","No of cells/volume (mm3)":762.523512657,"Total markers counted":413,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":0.000054899359000000006,"CE Gundersen":0.15,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_DG_BetaA","% Occupied by plaques":0.9947377211740001,"Region":"DG","Disease progression":12,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":46,"Total population estimated":1820.5,"Region volume estimation":10.0473,"CERAD Scale":"C","No of cells/volume (mm3)":181.192957312,"Total markers counted":46,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.11,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":12,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":3403.54,"Region volume estimation":7.3106800000000005,"CERAD Scale":"C","No of cells/volume (mm3)":465.557239545,"Total markers counted":86,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.11,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":12,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":3047.35,"Region volume estimation":6.1429800000000006,"CERAD Scale":"C","No of cells/volume (mm3)":496.070311152,"Total markers counted":77,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":0.000082100313,"CE Gundersen":0.09,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_SUB_BetaA","% Occupied by plaques":6.85397092602,"Region":"SUB","Disease progression":12,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":137,"Total population estimated":3765.22,"Region volume estimation":4.51017,"CERAD Scale":"C","No of cells/volume (mm3)":834.8288423719999,"Total markers counted":137,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":82,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":15,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":70,"Patient":"Az02","Post-mortem delay (hours)":2,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az02_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":12,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":15459.36,"Region volume estimation":4.95938,"CERAD Scale":"C","No of cells/volume (mm3)":3117.19610113,"Total markers counted":160,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":0},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":2,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":26134.07,"Region volume estimation":8.52308,"CERAD Scale":"C","No of cells/volume (mm3)":3066.27064395,"Total markers counted":207,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":0.000030922564,"CE Gundersen":0.05,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA1_BetaA","% Occupied by plaques":2.56144161368,"Region":"CA1","Disease progression":2,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":358,"Total population estimated":9839.03,"Region volume estimation":11.878,"CERAD Scale":"C","No of cells/volume (mm3)":828.3406297360001,"Total markers counted":358,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":2,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":110271.6,"Region volume estimation":10.4941,"CERAD Scale":"C","No of cells/volume (mm3)":10507.9616165,"Total markers counted":308,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":2,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":119994.43,"Region volume estimation":7.71276,"CERAD Scale":"C","No of cells/volume (mm3)":15557.9105275,"Total markers counted":758,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":2,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":54687.54,"Region volume estimation":8.638689999999999,"CERAD Scale":"C","No of cells/volume (mm3)":6330.53622714,"Total markers counted":566,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.13,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":2,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":7575.09,"Region volume estimation":6.2477,"CERAD Scale":"C","No of cells/volume (mm3)":1212.4605855,"Total markers counted":60,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":0.000042548652000000003,"CE Gundersen":0.1,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA3_BetaA","% Occupied by plaques":1.04479056577,"Region":"CA3","Disease progression":2,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":95,"Total population estimated":3759.72,"Region volume estimation":15.3113,"CERAD Scale":"C","No of cells/volume (mm3)":245.551977951,"Total markers counted":95,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":2,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":73037.03,"Region volume estimation":8.19585,"CERAD Scale":"C","No of cells/volume (mm3)":8911.46494872,"Total markers counted":204,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":2,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":112395.84,"Region volume estimation":8.9396,"CERAD Scale":"C","No of cells/volume (mm3)":12572.8041523,"Total markers counted":710,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.14,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":2,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":2137.1,"Region volume estimation":9.685989999999999,"CERAD Scale":"C","No of cells/volume (mm3)":220.638262067,"Total markers counted":54,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":2,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":9735.7,"Region volume estimation":8.31664,"CERAD Scale":"C","No of cells/volume (mm3)":1170.62900402,"Total markers counted":369,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":0.00004215698,"CE Gundersen":0.1,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_DG_BetaA","% Occupied by plaques":0.9628069376189999,"Region":"DG","Disease progression":2,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":109,"Total population estimated":4313.78,"Region volume estimation":18.8881,"CERAD Scale":"C","No of cells/volume (mm3)":228.386126715,"Total markers counted":109,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":2,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":6541.03,"Region volume estimation":8.653089999999999,"CERAD Scale":"C","No of cells/volume (mm3)":755.9184060260001,"Total markers counted":238,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":2,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":9146.8,"Region volume estimation":6.10824,"CERAD Scale":"C","No of cells/volume (mm3)":1497.45262138,"Total markers counted":142,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":0.000058789438,"CE Gundersen":0.08,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_SUB_BetaA","% Occupied by plaques":5.13923604446,"Region":"SUB","Disease progression":2,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":163,"Total population estimated":4479.78,"Region volume estimation":5.124569999999999,"CERAD Scale":"C","No of cells/volume (mm3)":874.176760196,"Total markers counted":163,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":81,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":79,"Patient":"Az03","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"SI","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az03_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":2,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":14493.16,"Region volume estimation":5.70656,"CERAD Scale":"C","No of cells/volume (mm3)":2539.73672405,"Total markers counted":150,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.1,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":9,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":19505.87,"Region volume estimation":8.12645,"CERAD Scale":"B","No of cells/volume (mm3)":2400.29410136,"Total markers counted":103,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":0.00001993507,"CE Gundersen":0.08,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA1_BetaA","% Occupied by plaques":4.781589102130001,"Region":"CA1","Disease progression":9,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":174,"Total population estimated":4782.1,"Region volume estimation":1.9937200000000002,"CERAD Scale":"B","No of cells/volume (mm3)":2398.58154605,"Total markers counted":174,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.11,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":9,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":11692.8,"Region volume estimation":4.68107,"CERAD Scale":"B","No of cells/volume (mm3)":2497.89043958,"Total markers counted":84,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":9,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":17888.35,"Region volume estimation":5.58985,"CERAD Scale":"B","No of cells/volume (mm3)":3200.14848341,"Total markers counted":113,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":9,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":80871.85,"Region volume estimation":6.31642,"CERAD Scale":"B","No of cells/volume (mm3)":12803.4313741,"Total markers counted":837,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.14,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":9,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":9468.87,"Region volume estimation":17.5884,"CERAD Scale":"B","No of cells/volume (mm3)":538.358804667,"Total markers counted":50,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":0.000050355328,"CE Gundersen":0.09,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA3_BetaA","% Occupied by plaques":2.95204230352,"Region":"CA3","Disease progression":9,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":127,"Total population estimated":3517.87,"Region volume estimation":6.00071,"CERAD Scale":"B","No of cells/volume (mm3)":586.242294662,"Total markers counted":127,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":9,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":45111.11,"Region volume estimation":7.1310199999999995,"CERAD Scale":"B","No of cells/volume (mm3)":6326.03891168,"Total markers counted":168,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":9,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":23195.93,"Region volume estimation":11.8524,"CERAD Scale":"B","No of cells/volume (mm3)":1957.06607944,"Total markers counted":844,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":1,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":9,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":40001.13,"Region volume estimation":10.9232,"CERAD Scale":"B","No of cells/volume (mm3)":3662.03401933,"Total markers counted":414,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":9,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":30552.67,"Region volume estimation":13.6157,"CERAD Scale":"B","No of cells/volume (mm3)":2243.9294344,"Total markers counted":772,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":0.000055294555,"CE Gundersen":0.07,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_DG_BetaA","% Occupied by plaques":2.98967585414,"Region":"DG","Disease progression":9,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":250,"Total population estimated":9893.99,"Region volume estimation":18.2991,"CERAD Scale":"B","No of cells/volume (mm3)":540.681782164,"Total markers counted":250,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":9,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":6173.86,"Region volume estimation":13.7594,"CERAD Scale":"B","No of cells/volume (mm3)":448.70125150800004,"Total markers counted":156,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.12,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":9,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":2928.62,"Region volume estimation":5.69193,"CERAD Scale":"B","No of cells/volume (mm3)":514.52143649,"Total markers counted":74,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":0.000030196979,"CE Gundersen":0.07,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_SUB_BetaA","% Occupied by plaques":13.2137133424,"Region":"SUB","Disease progression":9,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":243,"Total population estimated":6678.45,"Region volume estimation":1.52621,"CERAD Scale":"B","No of cells/volume (mm3)":4375.83949784,"Total markers counted":243,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":87,"Plaque AVG volume":"NaN","CE Gundersen":0.1,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":78,"Patient":"Az04","Post-mortem delay (hours)":5.5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"IV","Diabetes":"NaN","measure_id":"Az04_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":9,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":10241.84,"Region volume estimation":4.439030000000001,"CERAD Scale":"B","No of cells/volume (mm3)":2307.22477658,"Total markers counted":106,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":14,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":47533.71,"Region volume estimation":15.3683,"CERAD Scale":"C","No of cells/volume (mm3)":3092.97124601,"Total markers counted":251,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":0.000047241613,"CE Gundersen":0.08,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA1_BetaA","% Occupied by plaques":1.78120859238,"Region":"CA1","Disease progression":14,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":172,"Total population estimated":4727.13,"Region volume estimation":12.5374,"CERAD Scale":"C","No of cells/volume (mm3)":377.04228947,"Total markers counted":172,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":14,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":123787.03,"Region volume estimation":8.07739,"CERAD Scale":"C","No of cells/volume (mm3)":15325.1272998,"Total markers counted":461,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":14,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":221378.23,"Region volume estimation":12.3703,"CERAD Scale":"C","No of cells/volume (mm3)":17895.9467434,"Total markers counted":895,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":14,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":23672.17,"Region volume estimation":6.57228,"CERAD Scale":"C","No of cells/volume (mm3)":3601.82006853,"Total markers counted":245,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.16,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":14,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":5147.97,"Region volume estimation":12.5821,"CERAD Scale":"C","No of cells/volume (mm3)":409.150300824,"Total markers counted":37,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":0.000032414722999999996,"CE Gundersen":0.13,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA3_BetaA","% Occupied by plaques":0.593067870729,"Region":"CA3","Disease progression":14,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":62,"Total population estimated":1703.97,"Region volume estimation":9.31322,"CERAD Scale":"C","No of cells/volume (mm3)":182.96249847,"Total markers counted":62,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":14,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":46453.7,"Region volume estimation":5.51832,"CERAD Scale":"C","No of cells/volume (mm3)":8418.08738892,"Total markers counted":173,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":14,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":67120.89,"Region volume estimation":7.47588,"CERAD Scale":"C","No of cells/volume (mm3)":8978.32629737,"Total markers counted":424,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.18,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":14,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":1266.43,"Region volume estimation":11.3104,"CERAD Scale":"C","No of cells/volume (mm3)":111.970398925,"Total markers counted":32,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.13,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":14,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":1703.97,"Region volume estimation":18.227999999999998,"CERAD Scale":"C","No of cells/volume (mm3)":93.4809084924,"Total markers counted":62,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":0.000025255949,"CE Gundersen":0.09,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_DG_BetaA","% Occupied by plaques":0.518945659758,"Region":"DG","Disease progression":14,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":119,"Total population estimated":4709.54,"Region volume estimation":22.9203,"CERAD Scale":"C","No of cells/volume (mm3)":205.474622933,"Total markers counted":119,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.11,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":14,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":2308.6,"Region volume estimation":17.0739,"CERAD Scale":"C","No of cells/volume (mm3)":135.212224506,"Total markers counted":84,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.1,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":14,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":10048.59,"Region volume estimation":11.7207,"CERAD Scale":"C","No of cells/volume (mm3)":857.33701912,"Total markers counted":104,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":0.000031923748,"CE Gundersen":0.09,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_SUB_BetaA","% Occupied by plaques":1.53896938717,"Region":"SUB","Disease progression":14,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":135,"Total population estimated":3710.25,"Region volume estimation":7.696389999999999,"CERAD Scale":"C","No of cells/volume (mm3)":482.076661916,"Total markers counted":135,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":83,"Plaque AVG volume":"NaN","CE Gundersen":0.1,"MMSE (1)":23,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az05","Post-mortem delay (hours)":4,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V/VI","Diabetes":"NaN","measure_id":"Az05_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":14,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":7407.62,"Region volume estimation":8.40342,"CERAD Scale":"C","No of cells/volume (mm3)":881.500627126,"Total markers counted":92,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"Cardiopatía isquémica","Details of the cerebral atrophy":"Fronto-temporal","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":7,"Labeling":"AT8","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":24050.92,"Region volume estimation":9.68187,"CERAD Scale":"C","No of cells/volume (mm3)":2484.11928687,"Total markers counted":127,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":0.000021105465,"CE Gundersen":0.09,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA1_BetaA","% Occupied by plaques":1.1394717377399999,"Region":"CA1","Disease progression":7,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":129,"Total population estimated":3545.35,"Region volume estimation":6.56675,"CERAD Scale":"C","No of cells/volume (mm3)":539.89416378,"Total markers counted":129,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":7,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":48601.85,"Region volume estimation":6.785939999999999,"CERAD Scale":"C","No of cells/volume (mm3)":7162.13965935,"Total markers counted":181,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":7,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":48727.95,"Region volume estimation":6.9503699999999995,"CERAD Scale":"C","No of cells/volume (mm3)":7010.84258824,"Total markers counted":197,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":7,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":65315.86,"Region volume estimation":5.76224,"CERAD Scale":"C","No of cells/volume (mm3)":11335.1509135,"Total markers counted":676,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.12,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":7,"Labeling":"AT8","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":6500.36,"Region volume estimation":11.897,"CERAD Scale":"C","No of cells/volume (mm3)":546.386483988,"Total markers counted":73,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":0.000046726668,"CE Gundersen":0.24,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA3_BetaA","% Occupied by plaques":0.189115078897,"Region":"CA3","Disease progression":7,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":17,"Total population estimated":467.22,"Region volume estimation":11.5441,"CERAD Scale":"C","No of cells/volume (mm3)":40.4726223785,"Total markers counted":17,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":7,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":58537.04,"Region volume estimation":5.94644,"CERAD Scale":"C","No of cells/volume (mm3)":9844.0478673,"Total markers counted":218,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":7,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":29761.15,"Region volume estimation":8.56751,"CERAD Scale":"C","No of cells/volume (mm3)":3473.72223668,"Total markers counted":188,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":7,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":11691.15,"Region volume estimation":9.6292,"CERAD Scale":"C","No of cells/volume (mm3)":1214.13513064,"Total markers counted":121,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":7,"Labeling":"AT8","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":5540.64,"Region volume estimation":16.2104,"CERAD Scale":"C","No of cells/volume (mm3)":341.795390613,"Total markers counted":140,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":0.000040393805,"CE Gundersen":0.09,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_DG_BetaA","% Occupied by plaques":0.933270969781,"Region":"DG","Disease progression":7,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":125,"Total population estimated":4986.58,"Region volume estimation":21.5829,"CERAD Scale":"C","No of cells/volume (mm3)":231.04309430200001,"Total markers counted":125,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":7,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":4177.46,"Region volume estimation":12.593,"CERAD Scale":"C","No of cells/volume (mm3)":331.72873818799997,"Total markers counted":152,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.1,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":7,"Labeling":"AT8","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":10435.08,"Region volume estimation":9.18112,"CERAD Scale":"C","No of cells/volume (mm3)":1136.5802865,"Total markers counted":108,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":0.000065622273,"CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_SUB_BetaA","% Occupied by plaques":3.9822426320499997,"Region":"SUB","Disease progression":7,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":149,"Total population estimated":4095.02,"Region volume estimation":6.748069999999999,"CERAD Scale":"C","No of cells/volume (mm3)":606.843141817,"Total markers counted":149,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":76,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":69,"Patient":"Az06","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"V","Diabetes":"SI","measure_id":"Az06_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":7,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NO","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":14654.15,"Region volume estimation":5.6744699999999995,"CERAD Scale":"C","No of cells/volume (mm3)":2582.47025713,"Total markers counted":182,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Demencia","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Global","MMSE (2)":4},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":0,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":17391.79,"Region volume estimation":7.412210000000001,"CERAD Scale":"C","No of cells/volume (mm3)":2346.37038076,"Total markers counted":125,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":0.000014434571000000001,"CE Gundersen":0.09,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA1_BetaA","% Occupied by plaques":1.06582539404,"Region":"CA1","Disease progression":0,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":129,"Total population estimated":3545.35,"Region volume estimation":4.8015,"CERAD Scale":"C","No of cells/volume (mm3)":738.3838383839999,"Total markers counted":129,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":0,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":21436.8,"Region volume estimation":2.51173,"CERAD Scale":"C","No of cells/volume (mm3)":8534.67530348,"Total markers counted":154,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":0,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":42900.38,"Region volume estimation":4.78742,"CERAD Scale":"C","No of cells/volume (mm3)":8961.06462353,"Total markers counted":271,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":0,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":24155.26,"Region volume estimation":3.05764,"CERAD Scale":"C","No of cells/volume (mm3)":7899.96860324,"Total markers counted":250,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.18,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":0,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":6060.07,"Region volume estimation":12.0887,"CERAD Scale":"C","No of cells/volume (mm3)":501.30038796599996,"Total markers counted":32,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":0.000037035758,"CE Gundersen":0.12,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA3_BetaA","% Occupied by plaques":0.9805885920190001,"Region":"CA3","Disease progression":0,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":73,"Total population estimated":2006.28,"Region volume estimation":7.5775,"CERAD Scale":"C","No of cells/volume (mm3)":264.768063345,"Total markers counted":73,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":0,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":57194.44,"Region volume estimation":5.247330000000001,"CERAD Scale":"C","No of cells/volume (mm3)":10899.722334999999,"Total markers counted":213,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":0,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":92766.14,"Region volume estimation":7.91534,"CERAD Scale":"C","No of cells/volume (mm3)":11719.792201,"Total markers counted":586,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.14,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":0,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":6817.58,"Region volume estimation":11.4758,"CERAD Scale":"C","No of cells/volume (mm3)":594.083201171,"Total markers counted":49,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":0,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":14445.24,"Region volume estimation":13.6638,"CERAD Scale":"C","No of cells/volume (mm3)":1057.19053265,"Total markers counted":365,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":0.000052100832,"CE Gundersen":0.16,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_DG_BetaA","% Occupied by plaques":0.46128877838699994,"Region":"DG","Disease progression":0,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":39,"Total population estimated":1543.46,"Region volume estimation":17.4328,"CERAD Scale":"C","No of cells/volume (mm3)":88.5376990501,"Total markers counted":39,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":0,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":6760.9,"Region volume estimation":13.8943,"CERAD Scale":"C","No of cells/volume (mm3)":486.59522250099997,"Total markers counted":246,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":0,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":3655.28,"Region volume estimation":2.3311900000000003,"CERAD Scale":"C","No of cells/volume (mm3)":1567.98888122,"Total markers counted":133,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":0.000031864168,"CE Gundersen":0.18,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_SUB_BetaA","% Occupied by plaques":1.0359359477299999,"Region":"SUB","Disease progression":0,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":31,"Total population estimated":851.98,"Region volume estimation":2.62059,"CERAD Scale":"C","No of cells/volume (mm3)":325.109994314,"Total markers counted":31,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":89,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":"NaN","Depression/Anxiety/Mood disorders":"NaN","Age at diagnosis":89,"Patient":"Az07","Post-mortem delay (hours)":4.25,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az07_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":0,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"NaN","Total nucleators counted":"NaN","Total population estimated":5659.37,"Region volume estimation":1.38496,"CERAD Scale":"C","No of cells/volume (mm3)":4086.30574168,"Total markers counted":143,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"NaN","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"NaN","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":8,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":24528.87,"Region volume estimation":6.23688,"CERAD Scale":"C","No of cells/volume (mm3)":3932.87509139,"Total markers counted":238,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":0.000039817637,"CE Gundersen":0.08,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA1_BetaA","% Occupied by plaques":3.2096625519099997,"Region":"CA1","Disease progression":8,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":163,"Total population estimated":7466.31,"Region volume estimation":9.262369999999999,"CERAD Scale":"C","No of cells/volume (mm3)":806.09066578,"Total markers counted":163,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":8,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":26314.81,"Region volume estimation":3.36301,"CERAD Scale":"C","No of cells/volume (mm3)":7824.77899263,"Total markers counted":147,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":8,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":61219.12,"Region volume estimation":8.12397,"CERAD Scale":"C","No of cells/volume (mm3)":7535.61620735,"Total markers counted":297,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":8,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":37843.26,"Region volume estimation":3.9307800000000004,"CERAD Scale":"C","No of cells/volume (mm3)":9627.41745913,"Total markers counted":470,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.12,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":8,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":16000.45,"Region volume estimation":12.5582,"CERAD Scale":"C","No of cells/volume (mm3)":1274.10377283,"Total markers counted":69,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":0.00008559827300000001,"CE Gundersen":0.21,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA3_BetaA","% Occupied by plaques":1.05726103336,"Region":"CA3","Disease progression":8,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":23,"Total population estimated":1053.53,"Region volume estimation":8.52962,"CERAD Scale":"C","No of cells/volume (mm3)":123.51429489200001,"Total markers counted":23,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":8,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":60864.2,"Region volume estimation":5.222090000000001,"CERAD Scale":"C","No of cells/volume (mm3)":11655.1419068,"Total markers counted":340,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.04,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":8,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":112263.91,"Region volume estimation":9.009889999999999,"CERAD Scale":"C","No of cells/volume (mm3)":12460.075539200001,"Total markers counted":851,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":8,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":16908.69,"Region volume estimation":9.80591,"CERAD Scale":"C","No of cells/volume (mm3)":1724.33665004,"Total markers counted":210,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":8,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":23679.64,"Region volume estimation":25.9818,"CERAD Scale":"C","No of cells/volume (mm3)":911.3933599669999,"Total markers counted":359,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":0.000064788391,"CE Gundersen":0.14,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_DG_BetaA","% Occupied by plaques":1.16924751548,"Region":"DG","Disease progression":8,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":52,"Total population estimated":3429.92,"Region volume estimation":19.0053,"CERAD Scale":"C","No of cells/volume (mm3)":180.47176314,"Total markers counted":52,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":8,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":3206.39,"Region volume estimation":10.6147,"CERAD Scale":"C","No of cells/volume (mm3)":302.070713256,"Total markers counted":140,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.15,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":8,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":3100.12,"Region volume estimation":4.35228,"CERAD Scale":"C","No of cells/volume (mm3)":712.297922009,"Total markers counted":47,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":0.000050304152,"CE Gundersen":0.09,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_SUB_BetaA","% Occupied by plaques":4.86896474581,"Region":"SUB","Disease progression":8,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":124,"Total population estimated":5679.89,"Region volume estimation":5.8682300000000005,"CERAD Scale":"C","No of cells/volume (mm3)":967.905143459,"Total markers counted":124,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":85,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":7,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":77,"Patient":"Az08","Post-mortem delay (hours)":5.75,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"SI","measure_id":"Az08_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":8,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":10225.73,"Region volume estimation":4.82299,"CERAD Scale":"C","No of cells/volume (mm3)":2120.20551567,"Total markers counted":127,"Hypercholesterolemia":"SI","Visuospatial agnosia":"NaN","Details on family history of dementia":"NaN","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical / Cerebelosa","MMSE (2)":"NaN"},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.11,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":8,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":7301.77,"Region volume estimation":6.76807,"CERAD Scale":"C","No of cells/volume (mm3)":1078.85556739,"Total markers counted":82,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":0.000019727927999999998,"CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA1_BetaA","% Occupied by plaques":2.46529301058,"Region":"CA1","Disease progression":8,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":160,"Total population estimated":4397.33,"Region volume estimation":3.5188599999999997,"CERAD Scale":"C","No of cells/volume (mm3)":1249.64619223,"Total markers counted":160,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.13,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":8,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":15777.47,"Region volume estimation":3.07417,"CERAD Scale":"C","No of cells/volume (mm3)":5132.26984845,"Total markers counted":62,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.11,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":8,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":13139.23,"Region volume estimation":3.60391,"CERAD Scale":"C","No of cells/volume (mm3)":3645.82633862,"Total markers counted":83,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":8,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":45025.43,"Region volume estimation":3.0726299999999998,"CERAD Scale":"C","No of cells/volume (mm3)":14653.710339399999,"Total markers counted":466,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.12,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":8,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":10017.68,"Region volume estimation":9.151019999999999,"CERAD Scale":"C","No of cells/volume (mm3)":1094.70638246,"Total markers counted":72,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":0.000047851004000000004,"CE Gundersen":0.13,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA3_BetaA","% Occupied by plaques":0.9119434168889999,"Region":"CA3","Disease progression":8,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":67,"Total population estimated":1841.38,"Region volume estimation":9.66199,"CERAD Scale":"C","No of cells/volume (mm3)":190.57978739400002,"Total markers counted":67,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":8,"Labeling":"NISSL","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":35712.96,"Region volume estimation":3.84956,"CERAD Scale":"C","No of cells/volume (mm3)":9277.15375264,"Total markers counted":133,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":8,"Labeling":"NeuN","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":25803.55,"Region volume estimation":6.8960300000000005,"CERAD Scale":"C","No of cells/volume (mm3)":3741.797817,"Total markers counted":163,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":8,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":19034.36,"Region volume estimation":8.45172,"CERAD Scale":"C","No of cells/volume (mm3)":2252.12856081,"Total markers counted":197,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":8,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":9339.94,"Region volume estimation":13.5683,"CERAD Scale":"C","No of cells/volume (mm3)":688.364791462,"Total markers counted":236,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":0.000055345797,"CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_DG_BetaA","% Occupied by plaques":2.66488735562,"Region":"DG","Disease progression":8,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":169,"Total population estimated":6688.34,"Region volume estimation":13.8907,"CERAD Scale":"C","No of cells/volume (mm3)":481.497692701,"Total markers counted":169,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":8,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":4040.05,"Region volume estimation":7.38662,"CERAD Scale":"C","No of cells/volume (mm3)":546.941632303,"Total markers counted":147,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.11,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":8,"Labeling":"AT8","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":3363.96,"Region volume estimation":4.41378,"CERAD Scale":"C","No of cells/volume (mm3)":762.1494501310001,"Total markers counted":85,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":0.000026736404,"CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_SUB_BetaA","% Occupied by plaques":2.44133821093,"Region":"SUB","Disease progression":8,"Labeling":"BetaA","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":144,"Total population estimated":3957.6,"Region volume estimation":4.33418,"CERAD Scale":"C","No of cells/volume (mm3)":913.1138992839999,"Total markers counted":144,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":84,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":18,"Depression/Anxiety/Mood disorders":"NO","Age at diagnosis":76,"Patient":"Az09","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NO","Braak Scale":"VI","Diabetes":"NaN","measure_id":"Az09_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":8,"Labeling":"PHF1","Apraxia / Instrumental impairment":"SI","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":6846.65,"Region volume estimation":3.14414,"CERAD Scale":"C","No of cells/volume (mm3)":2177.59069253,"Total markers counted":173,"Hypercholesterolemia":"SI","Visuospatial agnosia":"SI","Details on family history of dementia":"Alzheimer","Details of cardiovascular diseases":"Hipertensión arterial","Details of the cerebral atrophy":"Cortico-subcortical","MMSE (2)":8},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.09,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA1_AT8","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":9,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":19896.21,"Region volume estimation":5.936719999999999,"CERAD Scale":"C","No of cells/volume (mm3)":3351.3808971999997,"Total markers counted":143,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":0.000035062645,"CE Gundersen":0.07,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA1_BetaA","% Occupied by plaques":14.5282341106,"Region":"CA1","Disease progression":9,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":241,"Total population estimated":6623.48,"Region volume estimation":1.5985200000000002,"CERAD Scale":"C","No of cells/volume (mm3)":4143.50774466,"Total markers counted":241,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA1_NISSL","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":9,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":45111.11,"Region volume estimation":3.58575,"CERAD Scale":"C","No of cells/volume (mm3)":12580.662344,"Total markers counted":168,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.06,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA1_NeuN","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":9,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":67526.55,"Region volume estimation":3.99635,"CERAD Scale":"C","No of cells/volume (mm3)":16897.056063699998,"Total markers counted":273,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA1_PHF1","% Occupied by plaques":"NaN","Region":"CA1","Disease progression":9,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":36909.26,"Region volume estimation":4.35273,"CERAD Scale":"C","No of cells/volume (mm3)":8479.56569785,"Total markers counted":382,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.13,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA3_AT8","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":9,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":10983.89,"Region volume estimation":14.5269,"CERAD Scale":"C","No of cells/volume (mm3)":756.106946424,"Total markers counted":58,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":0.000101973969,"CE Gundersen":0.09,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA3_BetaA","% Occupied by plaques":5.7658866412,"Region":"CA3","Disease progression":9,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":137,"Total population estimated":3765.22,"Region volume estimation":6.65907,"CERAD Scale":"C","No of cells/volume (mm3)":565.427304413,"Total markers counted":137,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA3_NISSL","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":9,"Labeling":"NISSL","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":50212.96,"Region volume estimation":6.887989999999999,"CERAD Scale":"C","No of cells/volume (mm3)":7289.92928271,"Total markers counted":187,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA3_NeuN","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":9,"Labeling":"NeuN","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":67754.11,"Region volume estimation":8.13743,"CERAD Scale":"C","No of cells/volume (mm3)":8326.22953439,"Total markers counted":428,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_CA3_PHF1","% Occupied by plaques":"NaN","Region":"CA3","Disease progression":9,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":16812.07,"Region volume estimation":14.4454,"CERAD Scale":"C","No of cells/volume (mm3)":1163.83554626,"Total markers counted":174,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.05,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_DG_AT8","% Occupied by plaques":"NaN","Region":"DG","Disease progression":9,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":16344.89,"Region volume estimation":12.4119,"CERAD Scale":"C","No of cells/volume (mm3)":1316.8725175000002,"Total markers counted":413,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":0.000064859621,"CE Gundersen":0.07,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_DG_BetaA","% Occupied by plaques":3.4291607272699998,"Region":"DG","Disease progression":9,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":216,"Total population estimated":8548.42,"Region volume estimation":16.1686,"CERAD Scale":"C","No of cells/volume (mm3)":528.705020843,"Total markers counted":216,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.07,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_DG_PHF1","% Occupied by plaques":"NaN","Region":"DG","Disease progression":9,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":6266.2,"Region volume estimation":16.8293,"CERAD Scale":"C","No of cells/volume (mm3)":372.33871878199994,"Total markers counted":228,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.2,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_SUB_AT8","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":9,"Labeling":"AT8","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":1028.98,"Region volume estimation":1.3166,"CERAD Scale":"C","No of cells/volume (mm3)":781.543369285,"Total markers counted":26,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":0.000055788676,"CE Gundersen":0.08,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_SUB_BetaA","% Occupied by plaques":10.182133951299999,"Region":"SUB","Disease progression":9,"Labeling":"BetaA","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":172,"Total population estimated":4727.13,"Region volume estimation":2.59003,"CERAD Scale":"C","No of cells/volume (mm3)":1825.1255777,"Total markers counted":172,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21},{"Decease age":80,"Plaque AVG volume":"NaN","CE Gundersen":0.08,"MMSE (1)":27,"Depression/Anxiety/Mood disorders":"SI","Age at diagnosis":71,"Patient":"Az10","Post-mortem delay (hours)":5,"Gender":"M","Initial behavior alteration":"NaN","Braak Scale":"V","Diabetes":"NaN","measure_id":"Az10_SUB_PHF1","% Occupied by plaques":"NaN","Region":"SUB","Disease progression":9,"Labeling":"PHF1","Apraxia / Instrumental impairment":"NaN","Language impairment":"SI","Total nucleators counted":"NaN","Total population estimated":17101.93,"Region volume estimation":3.9407400000000004,"CERAD Scale":"C","No of cells/volume (mm3)":4339.77628567,"Total markers counted":177,"Hypercholesterolemia":"NaN","Visuospatial agnosia":"SI","Details on family history of dementia":"DCL","Details of cardiovascular diseases":"NaN","Details of the cerebral atrophy":"Ganglios Basales","MMSE (2)":21}],"schema":{"dataset_type":"TABLE","index":"measure_id","attributes":{"measure_id":{"attribute_type":"CATEGORICAL","spatial":false,"key":true,"shape":[],"continuous":false,"name":"measure_id"},"Patient":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Patient"},"Labeling":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Labeling"},"Region":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Region"},"Region volume estimation":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"Region volume estimation"},"No of cells/volume (mm3)":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"No of cells/volume (mm3)"},"Total markers counted":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Total markers counted"},"Total population estimated":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"Total population estimated"},"Plaque AVG volume":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Plaque AVG volume"},"% Occupied by plaques":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"% Occupied by plaques"},"Total nucleators counted":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Total nucleators counted"},"CE Gundersen":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"CE Gundersen"},"Gender":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Gender"},"Decease age":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Decease age"},"Age at diagnosis":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Age at diagnosis"},"Disease progression":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Disease progression"},"Post-mortem delay (hours)":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":true,"name":"Post-mortem delay (hours)"},"Braak Scale":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Braak Scale"},"CERAD Scale":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"CERAD Scale"},"MMSE (1)":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"MMSE (1)"},"MMSE (2)":{"attribute_type":"QUANTITATIVE","spatial":false,"key":false,"shape":[],"continuous":false,"name":"MMSE (2)"},"Initial behavior alteration":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Initial behavior alteration"},"Depression/Anxiety/Mood disorders":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Depression/Anxiety/Mood disorders"},"Apraxia / Instrumental impairment":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Apraxia / Instrumental impairment"},"Language impairment":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Language impairment"},"Visuospatial agnosia":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Visuospatial agnosia"},"Diabetes":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Diabetes"},"Hypercholesterolemia":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Hypercholesterolemia"},"Details of cardiovascular diseases":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Details of cardiovascular diseases"},"Details of the cerebral atrophy":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Details of the cerebral atrophy"},"Details on family history of dementia":{"attribute_type":"CATEGORICAL","spatial":false,"key":false,"shape":[],"continuous":false,"name":"Details on family history of dementia"}},"quantitative_attrs":["% Occupied by plaques","Age at diagnosis","CE Gundersen","Decease age","Disease progression","MMSE (1)","MMSE (2)","No of cells/volume (mm3)","Plaque AVG volume","Post-mortem delay (hours)","Region volume estimation","Total markers counted","Total nucleators counted","Total population estimated"]},"selection":"joined_dselect"}},"conditions":{"Histological features":{"morpho_dselect":{"Region":{"name":"22786b91-06fa-450c-882a-f63808cbebd7","grammar":{"excluded_categories":[],"included_categories":["CA3","DG","CA1","SUB"],"name":"22786b91-06fa-450c-882a-f63808cbebd7","type":"categorical","enabled":true,"data":"Histological features","bins":null,"attr":"Region"}}}}},"layout":[{"x":0,"y":0,"w":6,"h":6,"i":"c0","handle":".card-anchor"},{"x":6,"y":0,"w":6,"h":6,"i":"c1","handle":".card-anchor"}],"cards":{"c0":{"kind":"regions","config":{},"key":"c0"},"c1":{"kind":"box","title":"Total population estimated split by: Patient","config":{"table":"Histological features","attr":"Total population estimated","facetAttr":"Patient"},"key":"c1","data":[[{"max":67754.11,"list":[19896.21,6623.48,45111.11,67526.55,36909.26,10983.89,3765.22,50212.96,67754.11,16812.07,16344.89,8548.42,6266.2,1028.98,4727.13,17101.93],"facetAttr":"Az10","min":1028.98,"subset":0},{"max":112263.91,"list":[24528.87,7466.31,26314.81,61219.12,37843.26,16000.45,1053.53,60864.2,112263.91,16908.69,23679.64,3429.92,3206.39,3100.12,5679.89,10225.73],"facetAttr":"Az08","min":1053.53,"subset":0},{"max":221378.23,"list":[47533.71,4727.13,123787.03,221378.23,23672.17,5147.97,1703.97,46453.7,67120.89,1266.43,1703.97,4709.54,2308.6,10048.59,3710.25,7407.62],"facetAttr":"Az05","min":1266.43,"subset":0},{"max":45025.43,"list":[7301.77,4397.33,15777.47,13139.23,45025.43,10017.68,1841.38,35712.96,25803.55,19034.36,9339.94,6688.34,4040.05,3363.96,3957.6,6846.65],"facetAttr":"Az09","min":1841.38,"subset":0},{"max":65315.86,"list":[24050.92,3545.35,48601.85,48727.95,65315.86,6500.36,467.22,58537.04,29761.15,11691.15,5540.64,4986.58,4177.46,10435.08,4095.02,14654.15],"facetAttr":"Az06","min":467.22,"subset":0},{"max":80871.85,"list":[19505.87,4782.1,11692.8,17888.35,80871.85,9468.87,3517.87,45111.11,23195.93,40001.13,30552.67,9893.99,6173.86,2928.62,6678.45,10241.84],"facetAttr":"Az04","min":2928.62,"subset":0},{"max":119994.43,"list":[26134.07,9839.03,110271.6,119994.43,54687.54,7575.09,3759.72,73037.03,112395.84,2137.1,9735.7,4313.78,6541.03,9146.8,4479.78,14493.16],"facetAttr":"Az03","min":2137.1,"subset":0},{"max":91654.32,"list":[32762.28,5441.7,91654.32,77094.05,35556.56,6678.45,1566.55,51555.55,57780.96,2453.71,11350.62,1820.5,3403.54,3047.35,3765.22,15459.36],"facetAttr":"Az02","min":1566.55,"subset":0},{"max":92766.14,"list":[17391.79,3545.35,21436.8,42900.38,24155.26,6060.07,2006.28,57194.44,92766.14,6817.58,14445.24,1543.46,6760.9,3655.28,851.98,5659.37],"facetAttr":"Az07","min":851.98,"subset":0},{"max":97515.26,"list":[26296.4,4892.03,37592.59,97515.26,28116.74,7635.69,1923.83,43231.48,51092.61,6183.75,12504.92,3126.5,1209.27,4947,2968.2,4274.21],"facetAttr":"Az01","min":1209.27,"subset":0}]]}}}';

module.exports = savedState;
